Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07162337 · ClinicalTrials.gov registry record · NA
BILe Acid-gut Microbiome Axis MODification Through Diet Education for Colorectal Cancer Prevention
A NA study, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07162337: Recruiting NA study, sponsored by Massachusetts General Hospital.
NCT07162337 is a NA study that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07162337, a NA study, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This research study is a prospective, single-arm clinical trial to assess the effect of a dietary intervention for more plant-based and less animal-based food intake on secondary bile acid production, gut microbiota, circulating biomarkers and gene expression associated with colonic bile acid receptor activation and colorectal cancer.
Interventions
- BEHAVIORAL Increased Plant-Based Diet and Decreased Animal-Based Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-06-18 |
| Est. Completion | 2028-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07162337
The ClinicalTrials.gov registry entry for NCT07162337 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Increased Plant-Based Diet and Decreased Animal-Based Diet is the first listed.
NCT07162337 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07162337 about?
NCT07162337 is a clinical study titled "BILe Acid-gut Microbiome Axis MODification Through Diet Education for Colorectal Cancer Prevention". This research study is a prospective, single-arm clinical trial to assess the effect of a dietary intervention for more plant-based and less animal-based food intake on secondary bile acid production, gut microbiota, circulating biomarkers and gene expression associated with colonic bile acid recept...
What is the current status of trial NCT07162337?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-06-18. Estimated completion is 2028-06-01.
What interventions are being tested in trial NCT07162337?
The interventions under investigation include: Increased Plant-Based Diet and Decreased Animal-Based Diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT07162337?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.